MedPath

A trial to assess the vision performance of spectacle lenses prescribed in smaller steps than standard spectacle lenses in adults who are short-sighted

Not Applicable
Completed
Conditions
Myopia
Eye - Diseases / disorders of the eye
Registration Number
ACTRN12620000619943
Lead Sponsor
nthalmic Pty Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
52
Inclusion Criteria

Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
Healthy adults aged 18 to 45 years of age (inclusive).
Willing to refrain from using soft contact lenses for the duration of the study.
Spherical refractive error between -1.00 and -6.00 D (inclusive) with cylinder power less than or equal to 1.00 D.
Can attain good vision: Best corrected visual acuity of 6/6 or better in each eye.
Willing to wear the study spectacles provided daily in lieu of their habitual spectacles for the duration of the study.
Willing to attend the scheduled study visits and adhere to instructions.

Exclusion Criteria

Be currently using topical ocular medication or have used topical ocular medication within 2 weeks of the first visit. Patients who are being treated bilaterally with marketed artificial tears can be considered, provided they discontinue use for 24 hours prior to each visit.
History of clinically significant or progressive ocular disease in either eye that would affect vision e.g. keratoconus.
Clinically significant anisometropia (difference in refractive power between the two eyes) of > 1.00D.
Rigid gas permeable lens wearer (including orthokeratology).
Any systemic disease that may affect ocular health e.g. Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis and systemic lupus erythematosus.
History of eye surgery or eye trauma within 6 months prior to enrolment in the study.
History of corneal refractive surgery.
The Investigator may, at his/her discretion, exclude anyone else who they believe may not be able to fulfil the study requirements, or if it is believed to be in the participant’s best interests.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath